Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

Delayed Data
As of Dec 02
 +0.14 / +0.91%
Today’s Change
Today|||52-Week Range
3 Drug Stocks Investors Shouldn't Touch With a 10-Foot Pole in 2017
Dec 01 / MotleyFool.com - Paid Partner Content
How to Trade Wednesday's Most Active Stocks -- Chesapeake Energy, American Eagle, Mor...
Nov 30 / TheStreet.com - Paid Partner Content
Frontrunning: December 1
Dec 01 / Investing Channel - Paid Partner Content
Valeant and Tribune Media Rebounds Not in Sight
Nov 30 / TheStreet.com - Paid Partner Content
SEC Discloses Correspondence Over Valeant's Accounting Practices
Nov 30 / TheStreet.com - Paid Partner Content
Dow Climbs as Crude Rally Lights Fire Under Energy Sector, S&P 500 Falls
Nov 30 / TheStreet.com - Paid Partner Content
Why Valeant Pharmaceuticals, Costamare, and First Bancorp Slumped Today
Nov 30 / MotleyFool.com - Paid Partner Content
Valeant Plummets on Reports of Salix Takeover Breakdown
Nov 30 / TheStreet.com - Paid Partner Content
Valeant, Salix, Sales Force and Asset Sales
Nov 30 / GuruFocus News - Paid Partner Content
Valeant (VRX) Ups Sales Force to Support Xifaxan/Relistor
Nov 30 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close15.31
Today’s open15.48
Day’s range15.18 - 15.75
Average volume (3 months)22,126,141
Market cap$5.3B
Dividend yield--
Data as of 4:00pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-131.25%
Earnings growth (this year)-46.13%
Earnings growth (next 5 years)+9.80%
Revenue growth (last year)+26.42%
P/E ratioNM


% change
IONSIonis Pharmaceutical...+1.67+4.04%
UTHRUnited Therapeutics ...-0.47-0.37%
MNKMallinckrodt Plc+0.51+0.96%
OPKOPKO Health Inc+0.09+0.87%
Data as of 4:02pm ET, 12/02/2016


Next reporting dateMarch 2, 2017
EPS forecast (this quarter)$1.25
Annual revenue (last year)$10.4B
Annual profit (last year)-$291.7M
Net profit margin-2.79%


Health Technology
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Quă©bec


Search for Jobs